Are routine breast and pelvic examinations necessary for women starting combined oral contraception?

Human Reproduction Update

Volumn 10, Issue 5, 2004, Pages 449-452

  Scott, A ^a   Glasier, A F ^a,b,c  

^a Lothian Health Family Planning   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Breast; Contraception; Hormonal; Pelvic; Screening

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ANXIETY; BREAST CANCER; BREAST EXAMINATION; CANCER SCREENING; CARDIOVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG CONTRAINDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; GYNECOLOGICAL EXAMINATION; HEALTH STATUS; HUMAN; MAMMOGRAPHY; ORAL CONTRACEPTION; PAPANICOLAOU TEST; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

BREAST; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, COMBINED; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; PELVIS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 4544348412     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/dmh031     Document Type: Review

References (34)

1. Baird DD, Dunson DB, Hill MC, Cousins D and Schectman JM (2003) High cumulative incidence of uterine leiomyoma in back and white women: ultrasound evidence. Am J Obstet Gynecol 188,100-107.
2. Beral V, Hermon C, Kay C, Hannaford P, Darby S and Reeves G (1999) Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46,000 women from Royal College of General Practitioners' oral contraception study. Br Med J 318,96-100.
3. Borgfeldt C and Andolf E (2000) Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women aged 25-40 years. Acta Obstet Gynecol Scand 79,202-207.
4. Collaborative Group on Hormonal Factors in Breast Cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347, 1713-1727.
5. Critchlow CW, Wolner-Hanssen P and Eschenbach DA (1995) Determinants of cervical ectropion and of cervicitis: age, oral contraception, specific cervical infection, smoking and douching. Am J Obstet Gynecol 173,534-543.
6. Department of Health and Social Security Working Group on Breast Cancer Screening (chair, Sir Patrick Forrest) (1986) Breast Cancer Screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. HMSO, London.
7. Grover SR and Quinn MA (1995) Is there any value in bimanual pelvic examination as a screening test? Med J Aust 162,408-410.
8. Harper C, Balistreri E, Boggess J, Leon K and Darney P (2001) Fam Plann Perspect 33,13-18.
9. Jacobs I, Stabile I, Bridges J, Kemsley P, Reynolds C, Grudzinskas J and Oram D (1988) Multimodal approach to screening for ovarian cancer. Lancet I,268-271.
10. Khader YS, Rice J, John L and Abueita O (2003) Oral contraceptive use and risk of myocardial infarction: a meta-analysis. Contraception 68,11-17.
11. Kosters JP and Gotzsche PC (2003) Regular self examination or clinical examination for early detection of breast cancer. Cochrane Database of Systematic Reviews 1,2003.
12. Larsen SB and Kragstrup J (1995) Experiences of the first pelvic examination in a random sample of Danish Teenagers. Acta Obstet Gynecol Scand 74,137-141.
13. Larsson G, Blohm F, Sundell G, Andersch B and Milsom I (1997) A longitudinal study of birth control and pregnancy outcome among women in a Swedish population. Contraception 56,6-16.
14. Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, Stampfer MJ and Hunter DJ (1998) A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70,432-439.
15. McPherson K, Steel CM and Dixon JM (2000) Breast cancer - epidemiology, risk factors, and genetics. Br Med J 321,624-628.
16. Oddens BJ (1996) Contraceptive use and attitudes in Italy 1993. Hum Reprod 11,533-539.
17. Oddens BJ and Milsom I (1996) Contraceptive practice and attitudes in Sweden 1994. Acta Obstet Gynecol Scand 75,932-940.
18. Oddens BJ, Visser A, Ph, Vemer HM, Everaerd W and Lehert, Ph (1994) Contraceptive use and attitudes in Great Britain. Contraception 49,73-86.
19. Parazzini F, La Vecchia C, Negri E, Cecchetti G and Fedele L (1988) Epidemiologic characteristics of women with uterine fibroids: a case control study. Obstet Gynecol 72,853-857.
20. Rohan TE and Miller AB (1999) A cohort study or oral contraceptive use and risk of benign breast disease. Int J Cancer 82,191-196.
21. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D and Casagrande JT (1986) Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 293,539-562.
22. Scottish Cancer Intelligence Unit (2003) ISD. NHS, Scotland.
23. Smith JS, Green J, Berrington de Gonzales A, Appleby P, Peto J, Plummer M, Franchesci S and Beral V (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361,1159-1167.
24. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF and Trussel J (2001) Clinical breast and pelvic examination requirements for hormonal contraception. Current practice vs evidence. J Am Med Assoc 285, 2232-2239.
25. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Po P, Zhao GL, Pan LD, Li W et al. (2002) Randomized trial of Breast Self Examination in Shanghai: Final Results. J Natl Cancer Inst 94, 1445-1457.
26. Toulemon L and Leridon H (1998) Contraceptive Practices and Trends in France. Fam Plann Perspect 30,114-120.
27. Tzingounis V, Cardamakis E, Ginopoulos P and Argiropoulos G (1996) Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormone replacement therapy). Anticancer Res 16,3997-4000.
28. United Kingdom Trial of Early Detection of Breast Cancer Group (1992) Specificity of screening in United Kingdom trial of early detection of breast cancer. Br Med J 304,346-349.
29. Waggoner SE (2003) Cervical Cancer. Lancet 361,2217-2225.
30. Wald NJ, Hackshaw AK and Frost CD (1999) When can a risk factor be used as a worthwhile screening test. Br Med J 319,1562-1565.
31. World Health Organization (1998) Cardiovascular Disease and Steroid Hormone Contraception Report of a WHO Scientific Group. WHO, Geneva, WHO Technical Report Series No. 877.
32. World Health Organization (2003) Selected Practice Recommendations for Contraceptive Use. WHO, Geneva.
33. World Health Organization (2004) Reproductive Health and Research. In Medical Eligibility Criteria for Contraceptive Use. WHO, Geneva.
34. Zoorob R, Anderson R, Cefalu C and Sidani M (2001) Cancer Screening Guidelines. Am Fam Phys 63,1101-1112.